Literature DB >> 19767141

Endoscopic management of hydrocephalus due to neurocysticercosis.

Jaime G Torres-Corzo1, J Humberto Tapia-Pérez, Roberto Rodriguez-Della Vecchia, Juan C Chalita-Williams, Martín Sánchez-Aguilar, José Juan Sánchez-Rodríguez.   

Abstract

OBJECTIVE: Hydrocephalus due to neurocysticercosis usually shows poor prognosis and shunt failure is a common complication. Neuroendoscopy has been suggested as treatment, but the indications remain unclear.
METHODS: A cohort of patients with clinical/radiological diagnosis of hydrocephalus due to NCC, treated between January 2002 and September 2006, were the subjects of the study. We excluded patients with tumors or those in whom diagnosis was not confirmed (histology/positive ELISA in CSF). Neuroendoscopy was offered as the first line of treatment. Shunt failure rate and Karnofsky index at 12 months were assessed.
RESULTS: Eighty-six patients (47 male) with a median age of 38 (9-79) were included in the study. Of them, 36.1% had a shunt before endoscopy and 97.7% had a Karnofsky index <80. We did not find the parasite in 18.6%, extraction was achieved in 79%, and in 87.2% an endoscopic third ventriculostomy (ETV) was performed. The median follow-up time was 43 months (1-72). Shunt failure was seen in 6.6% of patients with ETV in comparison to 27.2% in those without ETV. A hazard ratio of 0.22 (95% CI, 0.05-0.93) for shunt failure after ETV was calculated. At 12 months, 20.9% had a Karnofsky index <80.
CONCLUSION: Early extraction of parasite plus ETV might allow improving outcome and reducing shunt failure. Limitation of inflammatory stimulation by parasite antigens and improvement of CSF dynamics could be an explanation for these findings. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19767141     DOI: 10.1016/j.clineuro.2009.08.022

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  12 in total

Review 1.  Diagnosis and treatment of neurocysticercosis.

Authors:  Theodore E Nash; Hector H Garcia
Journal:  Nat Rev Neurol       Date:  2011-09-13       Impact factor: 42.937

Review 2.  Clinical symptoms, diagnosis, and treatment of neurocysticercosis.

Authors:  Hector H Garcia; Theodore E Nash; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

Review 3.  Neuroendoscopy for post-infective hydrocephalus in children.

Authors:  Chandrashekhar E Deopujari; Llewelyn Padayachy; Alias Azmi; Anthony Figaji; Saurav K Samantray
Journal:  Childs Nerv Syst       Date:  2018-08-11       Impact factor: 1.475

Review 4.  Clinical manifestations, diagnosis, and treatment of neurocysticercosis.

Authors:  Julio Sotelo
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

Review 5.  Cysticercosis of the central nervous system: how should it be managed?

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Curr Opin Infect Dis       Date:  2011-10       Impact factor: 4.915

6.  Multiple intraventricular neurocysticercal cysts treated with endoscopy without antiparasitic therapy.

Authors:  Theodoros Kelesidis; Nguyen Thian
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 3.707

7.  Commentary.

Authors:  Jaime G Torres Corzo
Journal:  J Neurosci Rural Pract       Date:  2012-01

8.  Endoscopic third ventriculostomy.

Authors:  Yad Ram Yadav; Vijay Parihar; Sonjjay Pande; Hemant Namdev; Moneet Agarwal
Journal:  J Neurosci Rural Pract       Date:  2012-05

9.  Neurocysticercosis, meningioma, and silent corticotroph pituitary adenoma in a 61-year-old woman.

Authors:  Maria Del Pilar Ramirez; Juan E Restrepo; Luis V Syro; Fabio Rotondo; Francisco J Londoño; Luis C Penagos; Humberto Uribe; Eva Horvath; Kalman Kovacs
Journal:  Case Rep Pathol       Date:  2012-12-30

10.  Reversible dementia due to neurocysticercosis: Improvement of the racemose type with antihistamines.

Authors:  Gislaine Cristina Lopes Machado-Porto; Leandro Tavares Lucato; Fábio Henrique de Gobbi Porto; Evandro Cesar de Souza; Ricardo Nitrini
Journal:  Dement Neuropsychol       Date:  2015 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.